ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Conexeu Sciences Inc.
3.76
-0.1273
-3.27%
成交量:
17.41万
成交额:
66.98万
市值:
1.06亿
市盈率:
-7.57
高:
4.09
开:
4.05
低:
3.65
收:
3.89
52周最高:
18.79
52周最低:
3.05
股本:
2,820.67万
流通股本:
1,554.15万
量比:
2.14
换手率:
1.12%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.4970
每股收益(LYR):
-0.3104
净资产收益率:
-332.94%
总资产收益率:
-170.73%
市净率:
18.14
市盈率(LYR):
-12.12
数据加载中...
总览
公司
新闻资讯
公告
医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹
美股速递
·
06/25
异动解读 | Conexeu Sciences上市首日表现不佳,盘中大跌7.41%
异动解读
·
05/22
美股异动 | Conexeu Sciences(CNXU.US)登陆美股市场 开盘跌超3.6%
智通财经
·
05/21
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/CNXU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNXU\",,,,,undefined,":{"symbol":"CNXU","market":"US","secType":"STK","nameCN":"Conexeu Sciences Inc.","latestPrice":3.7627,"timestamp":1791818477991,"preClose":3.89,"halted":0,"volume":174050,"delay":0,"changeRate":-0.03272493573264781,"floatShares":15541501,"shares":28206698,"eps":-0.497,"marketStatus":"交易中","change":-0.1273,"latestTime":"10-12 11:21:43 EDT","open":4.05,"high":4.09,"low":3.652,"amount":669780.08025,"amplitude":0.112596,"askPrice":3.87,"askSize":100,"bidPrice":3.67,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.497,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791835200000},"marketStatusCode":2,"adr":0,"listingDate":1779336000000,"exchange":"NASDAQ","adjPreClose":3.89,"preHourTrading":{"tag":"盘前","latestPrice":4.15,"preClose":3.89,"latestTime":"09:05 EDT","volume":1610,"amount":6636.636867,"timestamp":1791810339590,"change":0.26,"changeRate":0.066838,"amplitude":0.047815},"postHourTrading":{"tag":"盘后","latestPrice":3.9961,"preClose":3.89,"latestTime":"19:57 EDT","volume":4908,"amount":19306.2941,"timestamp":1791590230907,"change":0.1061,"changeRate":0.027275,"amplitude":0.046041},"volumeRatio":2.13737},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNXU\",,,,,undefined,":{"symbol":"CNXU","floatShares":15541501,"roa":"-170.73%","roe":"-332.94%","lyrEps":-0.310358,"volumeRatio":2.13737,"shares":28206698,"dividePrice":0,"high":4.09,"amplitude":0.112596,"preClose":3.89,"low":3.652,"week52Low":3.0501,"pbRate":"18.14","week52High":18.7915,"institutionHeld":0,"latestPrice":3.7627,"committee":0.333333,"eps":-0.497,"divideRate":0,"volume":174050,"delay":0,"ttmEps":-0.497,"open":4.05,"prevYearClose":13.5,"prevWeekClose":3.89,"prevMonthClose":3.57,"prevQuarterClose":3.57,"fiveDayClose":3.12,"twentyDayClose":5,"sixtyDayClose":9.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNXU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-14","symbol":"CNXU","fiscalQuarterEnding":"2026/07","expectedEps":-0.1,"name":null,"time":"盘后","type":"earning","dateTimestamp":1789358400000,"reportTimeType":"post","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNXU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNXU\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNXU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNXU","date":"2026-10-09","current":-7.525151,"percent":0.968421,"low":-79.55424,"twenty":-53.303701,"median":-33.194451,"eighty":-18.474404,"high":-6.417374,"avg":-34.688351,"sd":18.65648,"marketCap":97313108},"quantilePoints":[{"date":"2026-05-22","current":-61.707651,"twenty":-61.707651,"median":-61.707651,"eighty":-61.707651,"marketCap":330278847},{"date":"2026-05-29","current":-54.672884,"twenty":-65.607461,"median":-64.327983,"eighty":-60.300698,"marketCap":292626553},{"date":"2026-06-05","current":-75.541118,"twenty":-76.3343,"median":-65.838806,"eighty":-60.437616,"marketCap":404319936},{"date":"2026-06-12","current":-57.26961,"twenty":-72.783868,"median":-65.815199,"eighty":-60.63119,"marketCap":306525051},{"date":"2026-06-18","current":-61.471585,"twenty":-72.022319,"median":-64.327983,"eighty":-56.504756,"marketCap":329015347},{"date":"2026-06-26","current":-37.989619,"twenty":-69.581868,"median":-61.589618,"eighty":-54.125211,"marketCap":273470132},{"date":"2026-07-02","current":-38.138306,"twenty":-67.458218,"median":-61.182094,"eighty":-40.651122,"marketCap":274540465},{"date":"2026-07-10","current":-36.837292,"twenty":-66.325102,"median":-57.26961,"eighty":-39.424451,"marketCap":265175050},{"date":"2026-07-17","current":-39.067602,"twenty":-65.494149,"median":-53.988293,"eighty":-38.257256,"marketCap":281230048},{"date":"2026-07-24","current":-34.012232,"twenty":-64.738738,"median":-41.558115,"eighty":-37.945013,"marketCap":244838719},{"date":"2026-07-31","current":-32.822733,"twenty":-64.002212,"median":-40.591647,"eighty":-36.004643,"marketCap":236276053},{"date":"2026-08-07","current":-31.484547,"twenty":-62.500833,"median":-39.94114,"eighty":-34.153485,"marketCap":226643055},{"date":"2026-08-14","current":-29.625955,"twenty":-61.660438,"median":-39.067602,"eighty":-32.859905,"marketCap":213263890},{"date":"2026-08-21","current":-35.053043,"twenty":-61.471585,"median":-38.101134,"eighty":-33.023461,"marketCap":252331051},{"date":"2026-08-28","current":-26.168974,"twenty":-61.355789,"median":-37.989619,"eighty":-31.008748,"marketCap":188378643},{"date":"2026-09-04","current":-19.589559,"twenty":-60.536268,"median":-36.985979,"eighty":-29.090681,"marketCap":141016399},{"date":"2026-09-11","current":-15.798031,"twenty":-59.110925,"median":-36.446988,"eighty":-28.547972,"marketCap":113722902},{"date":"2026-09-18","current":-20.767449,"twenty":-57.26961,"median":-35.313246,"eighty":-27.023926,"marketCap":149495499},{"date":"2026-09-25","current":-8.197678,"twenty":-55.357476,"median":-34.88577,"eighty":-25.927357,"marketCap":111698524},{"date":"2026-10-02","current":-6.872801,"twenty":-54.672884,"median":-33.752029,"eighty":-19.589559,"marketCap":93646237},{"date":"2026-10-09","current":-7.141916,"twenty":-53.303701,"median":-33.194451,"eighty":-18.474404,"marketCap":97313108}],"updateTime":1791818500899},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNXU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1136601431","title":"医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹","url":"https://stock-news.laohu8.com/highlight/detail?id=1136601431","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136601431?lang=zh_cn&edition=fundamental","pubTime":"2026-06-25 21:06","pubTimestamp":1782392808,"startTime":"0","endTime":"0","summary":"医美行业巨头们已证实,由GLP-1减肥药引发的面部脂肪流失现象——“司美格鲁肽脸”——是真实存在的副作用。这一市场新动态,正为专注于再生医学的医美公司开辟出全新的竞争赛道。一家新近上市的再生医学领域参与者,已明确表示将瞄准这一快速增长的需求。市场分析指出,“司美格鲁肽脸”现象催生的不仅是新的治疗需求,更是一个潜在的交叉增长市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU2089984988.USD","BK4139","BK4198","LU2237443978.SGD","BK4534","IE00BJT1NW94.SGD","LU0795875169.SGD","LU1551013425.SGD","IE00BFTCPJ56.SGD","IE0002270589.USD","LU0234572021.USD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU1244550494.USD","LU0069063385.USD","SG9999015986.USD","IE000BZT7R73.USD","IE00BDGV0183.EUR","LU1496350171.SGD","LU2112291526.USD","LU2089284900.SGD","LU0289739343.SGD","LU0122379950.USD","BK4533","LU0211328371.USD","LU0114720955.EUR","LU0310799852.SGD","LU1989772923.USD","IE000F7OJYX1.SGD","LU2089283258.USD","LU0203345920.USD","LU1244550221.USD","LU0211327993.USD","CNXU","LU0689626769.HKD","BK4588","LU0882574055.USD","LU0861579265.USD","IE0000B7K699.USD","LU0949170772.SGD","LU0098860793.USD","LU2129689514.USD","LU2129689605.HKD","LU0820561818.USD","LU0738911758.USD","BK4550","LU1983299246.USD","SG9999001440.SGD","SG9999003800.SGD","LU0256863902.USD","LU0965509283.SGD","LU1670628061.USD","LU1934455194.USD","LU2129689431.USD","IE00BVYPNV92.GBP","LU1732799900.SGD","LU1839511570.USD","LU0472753341.HKD","LU0289739699.SGD","IE000MB6IJN5.SGD","LU0942090050.USD","LU1093756325.SGD","LU0256863811.USD","LU1023059063.AUD","LU0058720904.USD","BK4585","LU0198837287.USD","LU0432979614.USD","LU2237443382.USD","IE00B3PB1722.GBP","LU2237443465.HKD","BK4082","LU0689472784.USD","IE00BBT3K403.USD","IE00BN8TJ469.HKD","LU0057025933.USD","LU0203347892.USD","LU0985320562.USD","LU1162221912.USD","IE00B2B36J28.USD","LU0859254822.USD","LU2023251221.USD","LU0820561909.HKD","INMD","LU0417517546.SGD","BK4566","LU0029864427.USD","LU2087621335.USD","BK4559","LU0868494708.USD","LU1670627923.USD","LU0868494617.USD","LU1061106388.HKD","IE00BLSP4239.USD","LU0158827948.USD","LU1585245621.USD","LU0320765646.SGD","LU2237443622.USD","LU1074936037.SGD","LU0965509101.SGD","LU0943347566.SGD","LU2468319806.SGD","IE00BSNM7G36.USD","SG9999015952.SGD","LU1732800096.USD","LU0545039389.USD","IE00B19Z3581.USD","IE000WAW04H5.SGD","IE0002141913.USD","LU1496350502.SGD","LU0795875086.SGD","IE0009355771.USD","SG9999015978.USD","ESTA","IE00BVYPNW00.USD","LU1037948541.HKD","LU0553294199.USD","LU0456855351.SGD","LU0823416689.USD","LU0912757837.SGD","LU1057294990.SGD","LU2133065610.SGD","LU0708994859.HKD","LU1989771016.USD","LU1037948897.HKD","LU1093756168.USD","LU1244550577.SGD","LU1430594728.SGD","IE0004445239.USD","LU1003077747.HKD","LU0128525929.USD","LU2347655156.SGD","LU1718418525.SGD","LU0170899867.USD","LU1291159041.SGD","LU0511384066.AUD","LU2237443549.SGD","SG9999015945.SGD","LU0965508806.USD","LU1934455277.USD","BK4581","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0124676726.USD","LU2324357040.USD","IE00BLSP4452.SGD","LU0965509010.AUD","IE00B42XCP33.USD","LU2357627491.SGD","LU0661504455.SGD","ABBV","LU1989772840.SGD","LU0289961442.SGD","LU1929549753.HKD","LU1934455863.HKD","LU2237443895.HKD","IE00BGHQF631.EUR","IE000SO60NU8.SGD","LU1267930490.SGD","IE00B4R5TH58.HKD","LU1551013342.USD","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139516091","title":"异动解读 | Conexeu Sciences上市首日表现不佳,盘中大跌7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139516091","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139516091?lang=zh_cn&edition=fundamental","pubTime":"2026-05-22 01:40","pubTimestamp":1779385255,"startTime":"0","endTime":"0","summary":"Conexeu Sciences(CNXU.US)今日盘中股价大跌7.41%,引起市场关注。消息面上,该公司于周四登陆美股市场,IPO价格为13.5美元,但开盘即跌破发行价,报13.01美元,跌幅超过3.6%。作为一家早期医疗科技公司,Conexeu Sciences专注于开发基于胶原蛋白的再生医学材料,用于伤口修复、牙科软组织修复及医美领域,但其市场首秀并未获得投资者热烈追捧。公司核心产品为CXU™生物支架材料,旨在模拟人体细胞外基质结构以促进组织再生,但此次股价表现可能反映了市场对其商业前景的谨慎态度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637523358","title":"美股异动 | Conexeu Sciences(CNXU.US)登陆美股市场 开盘跌超3.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637523358","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637523358?lang=zh_cn&edition=fundamental","pubTime":"2026-05-21 23:57","pubTimestamp":1779379070,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周四,Conexeu Sciences(CNXU.US)登陆美股市场,开盘股价跌超3.6%,报13.01美元。IPO价格为13.5美元。Conexeu Sciences是一家美国早期医疗科技公司,专注于开发基于胶原蛋白的再生医学材料,主要用于伤口修复、牙科软组织修复以及医美领域。公司总部位于内华达州Reno,其核心产品为CXU™生物支架材料,旨在通过模拟人体细胞外基质(ECM)结构,促进组织再生与愈合。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NXU.U","CNXU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}